IP Library Granted Patent US 8,927,270
Granted Patent B2
US 8,927,270 · App. 12/449,037 · Granted Jan 6, 2015

Turkey herpesvirus vectored recombinant containing avian influenza genes

Inventors: Motoyuki Esaki (Lenexa, KS); Lauren Elizabeth Jensen (Kansas City, MO); Kristi M. Dorsey (Chadds Ford, PA)
Assignee: Zeon Corporation
A61K39/145C07K14/11C12N15/869C12N15/63C12N2710/16143C12N7/00C12N15/85C12N2830/60C12N2830/34A61K2039/5256C12N15/86C12N2710/16443C12N2760/16134
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,270
App. No.
12/449,037
Granted
Jan 6, 2015
Kind
B2
Abstract

The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.

Claims (6)

1. A recombinant turkey herpesvirus comprising a hemagglutinin gene of avian influenza virus and the cytomegalovirus immediate early promoter, wherein said hemagglutinin gene is under control of said promoter,

wherein said avianinfluenza virus is H5 subtype.

2. A recombinant turkey herpesvirus comprising a hemagglutinin gene of avian influenza virus and the cytomegalovirus immediate early promoter, wherein said hemagglutinin gene is under control of said promoter,

wherein said avian influenza virus is A/Turkey/Wisconsin/68 (H5N9) strain.

3. A recombinant turkey herpesvirus comprising a hemagglutinin gene of avian influenza virus and the cytomegalovirus immediate early promoter, wherein said hemagglutinin gene is under control of said promoter,

wherein the nucleotide sequence of said hemagglutinin gene is shown in SEQ ID NO: 1.

Assignments (3)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 2, 2024
From: CEVA ANIMAL HEALTH, LLC; BIOMUNE COMPANY; THUNDERSHIRT, LLC
To: NATIXIS, AS SECURITY AGENT
Reel/Frame 066163/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2017
From: ZEON CORPORATION
To: BIOMUNE COMPANY
Reel/Frame 041939/0800 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2009
From: ESAKI, MOTOYUKI; JENSEN, LAUREN ELIZABETH; DORSEY, KRISTI M.
To: ZEON CORPORATION
Reel/Frame 023022/0188 →
Continuity (2)
Continuation 11729978 · Mar 30, 2007
Related Publication 20100092510A1 · Apr 15, 2010